학술논문
798P NeoTrio – Optimal neoadjuvant (NAT) sequencing of anti-PD-1 and BRAF targeted therapy (TT) in BRAF mutant stage III melanoma: Results of histopathological analysis
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S909-S909
Subject
Language
ISSN
0923-7534